Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $74.96 +1.72%
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
MOV, SJM, LITB, More
Financial Fact:
General and administrative: 10.25M
Today's EPS Names:
MOV, SJM, LITB, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of $0.03, $0.19 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $29.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Deutsche Bank Upgrades Yizumi Holdings (300415:CH) to Buy
- Knight Transportation (KNX) Reiterated at Market Outperform by Citizens Post 75th ACT Seminar
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
